Vascular Graft Solutions
Tel Aviv, Israel· Est.
Israeli med‑tech firm delivering CE‑marked and FDA‑cleared devices that improve CABG durability and safety.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Israeli med‑tech firm delivering CE‑marked and FDA‑cleared devices that improve CABG durability and safety.
Cardiology
Technology Platform
Mechanical support for saphenous vein grafts via external stenting (VEST) and clampless proximal anastomosis using integrated punching and sealing (VIOLA).
Opportunities
U.S.
FDA approval for VEST, expansion into peripheral vascular markets, and partnership opportunities with major cardiac surgery device manufacturers.
Risk Factors
Regulatory delays, reimbursement challenges, and competition from established vascular graft and anastomosis device manufacturers.
Competitive Landscape
Competes with Medtronic, Gore, and other cardiac surgery device firms; VGS differentiates through proven clinical data, clampless anastomosis, and external vein graft support technology.